Bank of America’s Strongbridge Biopharma plc. SBBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-10,611
| Closed | -$22K | – | 9057 |
|
|
2021
Q3 | $22K | Sell |
10,611
-38,315
| -78% | -$89.2K | ﹤0.01% | 7368 |
|
|
2021
Q2 | $145K | Buy |
48,926
+16,078
| +49% | +$42.5K | ﹤0.01% | 6298 |
|
|
2021
Q1 | $91K | Buy |
32,848
+21,414
| +187% | +$64.6K | ﹤0.01% | 6431 |
|
|
2020
Q4 | $28K | Buy |
11,434
+8,965
| +363% | +$21.6K | ﹤0.01% | 6510 |
|
|
2020
Q3 | $6K | Sell |
2,469
-2,952
| -54% | -$9.95K | ﹤0.01% | 6567 |
|
|
2020
Q2 | $20K | Buy |
5,421
+4,898
| +937% | +$14.7K | ﹤0.01% | 6272 |
|
|
2020
Q1 | $1K | Sell |
523
-3,729
| -88% | -$9.69K | ﹤0.01% | 6767 |
|
|
2019
Q4 | $9K | Sell |
4,252
-1,344
| -24% | -$2.58K | ﹤0.01% | 6672 |
|
|
2019
Q3 | $14K | Sell |
5,596
-317
| -5% | -$851 | ﹤0.01% | 6659 |
|
|
2019
Q2 | $18K | Buy |
5,913
+5,713
| +2,857% | +$21K | ﹤0.01% | 6598 |
|
|
2019
Q1 | $1K | Sell |
200
-2,406
| -92% | -$11.8K | ﹤0.01% | 7029 |
|
|
2018
Q4 | $12K | Sell |
2,606
-8,435
| -76% | -$41.2K | ﹤0.01% | 6606 |
|
|
2018
Q3 | $54K | Sell |
11,041
-4,149
| -27% | -$21.2K | ﹤0.01% | 6187 |
|
|
2018
Q2 | $91K | Buy |
15,190
+11,859
| +356% | +$86.8K | ﹤0.01% | 5840 |
|
|
2018
Q1 | $29K | Sell |
3,331
-4,813
| -59% | -$36K | ﹤0.01% | 6259 |
|
|
2017
Q4 | $59K | Buy |
8,144
+7,128
| +702% | +$44.5K | ﹤0.01% | 5998 |
|
|
2017
Q3 | $7K | Buy |
+1,016
| New | +$7.01K | ﹤0.01% | 6653 |
|
|
2016
Q3 | – | Sell |
-3,114
| Closed | -$12K | – | 7465 |
|
|
2016
Q2 | $12K | Hold |
3,114
| – | – | ﹤0.01% | 6442 |
|
|
2016
Q1 | $14K | Hold |
3,114
| – | – | ﹤0.01% | 6286 |
|
|
2015
Q4 | $24K | Buy |
+3,114
| New | +$22.4K | ﹤0.01% | 6361 |
|
Bank of America's SBBP Position: Q4 2021 in Review
Bank of America sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 10,611 shares — an estimated $22K sold.
Bank of America first reported a position in SBBP in Q4 2015 and held it in 20 quarters. The position peaked at $145K in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.
- Bank of America reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
- Bank of America sold 10,611 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $22K.
- Bank of America first reported a position in Strongbridge Biopharma plc. in Q4 2015 and held it in 20 quarters.
- Bank of America's Strongbridge Biopharma plc. position peaked at $145K in Q2 2021.
- 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.
Based on Bank of America's 13F filing for Q4 2021, filed 8 Feb 2022.